StockTipsArenaBeta

BUY Alkem Laboratories Limited — Prakash Gaba

BUYAlkem Laboratories Limited

byPrakash GabaHorizon: NA (inferred Swing (≤2wk))17 Sept 2026via CNBC Awaaz.

Entry₹5,378.5Inferred
Target₹5,400
Total upside +0.40% (call closed)
Stop loss₹5,300-1.46% risk
Exit₹5,400Target hit — time not yet verified
Target hit+0.40%0.00%upside left
Follow Prakash Gaba for new calls(30% target hit, 216 closed calls)Get alertsWatch ALKEM for new buy/sell callsGet alertsSee 258 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 18 Sept, 3:54 pm IST
3 supporting0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·18 Sept · today

Alkem Laboratories Limited has launched NeuCeno (cenobamate) for treating partial-onset seizures in adult patients.

BSE · Company Update·16 Sept · 2d ago

(opens in new tab)

Alkem Laboratories has launched Renocia ExoTM, a hair growth serum based on patented Ginsenoside Exosomes, marking a significant product introduction in India.

BSE · Company Update·8 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.